-+ 0.00%
-+ 0.00%
-+ 0.00%
Medicus Pharma regains conditional compliance with Nasdaq minimum equity requirement
Share
Listen to the news
Medicus Pharma regains conditional compliance with Nasdaq minimum equity requirement
  • Medicus Pharma regained compliance with Nasdaq's $2.5 million minimum shareholders' equity requirement under a November 18, 2026, conditional notice.
  • The determination followed approximately $4.25 million in equity financings and the exchange of $10.5 million in Streeterville Capital indebtedness for non-convertible preferred shares.
  • Continued compliance must be demonstrated in the next periodic report for the period ending December 31, 2026.
  • Failure to meet the requirement could trigger delisting, subject to appeal to a Nasdaq Hearings Panel.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611190730PRIMZONEFULLFEED9880981) on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending